Literature DB >> 2664371

Aneuploidy as a prognostic factor in breast cancer.

A von Rosen1.   

Abstract

The predictive value of nuclear DNA content in mammary carcinoma is still under debate in spite of several reports indicating a relationship between DNA ploidy and prognosis. The impact of differences in methodology on the evaluation of DNA data is discussed, and a recent study demonstrating DNA ploidy as a statistically significant prognostic variable on a prospective material of breast cancer patients is presented.

Entities:  

Mesh:

Year:  1989        PMID: 2664371     DOI: 10.1007/bf02985233

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  21 in total

1.  A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling.

Authors:  R W McDivitt; K R Stone; R B Craig; J S Meyer
Journal:  Lab Invest       Date:  1985-03       Impact factor: 5.662

2.  Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county.

Authors:  G Fagerberg; L Baldetorp; O Gröntoft; B Lundström; J C Månson; B Nordenskjöld
Journal:  Acta Radiol Oncol       Date:  1985 Nov-Dec

3.  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.

Authors:  D W Hedley; M L Friedlander; I W Taylor
Journal:  Cytometry       Date:  1985-07

4.  Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.

Authors:  G Auer; E Eriksson; E Azavedo; T Caspersson; A Wallgren
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

5.  Prognostic significance of the DNA content of human breast cancer.

Authors:  C S Dowle; A Owainati; A Robins; K Burns; I O Ellis; C W Elston; R W Blamey
Journal:  Br J Surg       Date:  1987-02       Impact factor: 6.939

6.  Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

Authors:  D W Hedley; C A Rugg; A B Ng; I W Taylor
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

7.  DNA ploidy and survival in breast cancer patients.

Authors:  C J Cornelisse; C J van de Velde; R J Caspers; A J Moolenaar; J Hermans
Journal:  Cytometry       Date:  1987-03

8.  DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma.

Authors:  C Klintenberg; A Wallgren; K Bjelkenkrantz; J Carstenssen; S Humla; B Nordenskjöld; L Skoog
Journal:  Acta Radiol Oncol       Date:  1985 May-Jun

9.  Prognostic significance of DNA measurements in 409 consecutive breast cancer patients.

Authors:  A G Fallenius; G U Auer; J M Carstensen
Journal:  Cancer       Date:  1988-07-15       Impact factor: 6.860

10.  DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.

Authors:  A D Baildam; J Zaloudik; A Howell; D M Barnes; L Turnbull; R Swindell; M Moore; R A Sellwood
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

View more
  1 in total

1.  Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival.

Authors:  Wen-Ting Liao; Yan Feng; Men-Lin Li; Guang-Lin Liu; Man-Zhi Li; Mu-Sheng Zeng; Li-Bing Song
Journal:  Chin J Cancer       Date:  2011-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.